Objective-Cell surface nucleolin (NCL) plays fundamental roles in tumor angiogenesis. However, the mechanism underlying its surface translocation remains obscure. The present study discovered that heat shock cognate 70 (Hsc70) is essential in both the surface translocation and the angiogenic function of NCL. Methods and Results-We identified that Hsc70 interacted with NCL in endothelial cells via the peptide-binding domain of Hsc70 and the RNA-binding domain of NCL. Functional knockdown of Hsc70 remarkably inhibited the expression of surface NCL, which was rescued by wild-type Hsc70 rather than its truncations. Phosphorylation of NCL by either protein kinase C-ξ or casein kinase 2 mediated its interaction with Hsc70 and the surface expression. Hsc70 regulated NCL translocation via stabilizing NCL and enhancing its interaction with nonmuscle myosin heavy chain 9. Moreover, Hsc70 was associated with NCL-induced endothelial cell migration and tubule formation in vitro and angiogenesis in both matrigel plugs and xenograft tumors. Tissue array analysis revealed that the expression levels of NCL and Hsc70 were intimately correlated in human lung adenocarcinomas. Conclusion-Our study demonstrates that Hsc70 is a prerequisite for the surface translocation and angiogenic function of NCL, which suggests strategies to target both Hsc70 and NCL for more effective antiangiogenic therapies. (Arterioscler Thromb Vasc Biol. 2012;32:e126-e134.)
N ucleolin (NCL) is a ubiquitous, nonhistone phosphoprotein with remarkably versatile functions in transcription, cell proliferation, and virus infection. 1 It is predominantly expressed in the nucleolus and regulates fundamental aspects of ribosome biogenesis. 2 Many studies have reported that NCL is also localized on the cell surface and serves as a receptor for multiple ligands, such as virus, cytokines, and DNA nanoparticles. [3] [4] [5] Surface NCL form clusters on ligand binding and the ligand-NCL complex is considered to be actively internalized. 6 Since the last decade, the role of surface NCL in angiogenesis and tumor growth has been extensively studied. Surface NCL has been identified as a marker in angiogenic blood vessels. 7, 8 The blockade of surface NCL can impede angiogenesis, normalize tumor vasculature, and suppress tumor growth. [8] [9] [10] NCL is an endostatin receptor that mediates both the antiangiogenic and antilymphangiogenic functions of endostatin. [11] [12] [13] These studies reveal the crucial roles of surface NCL in angiogenesis and tumorigenesis, which has emerged as a promising target for cancer diagnosis and therapy. Consequently, it is essential to understand the mechanism of NCL expression on the cell surface.
Accumulating evidences have suggested that the expression of surface NCL is attributed to its active translocation. Vascular endothelial growth factor and extracellular matrix can mobilize NCL to the surface of endothelial cells, 8 whereas nonmuscle myosin heavy chain 9 (MyH9) provides an anchorage for NCL translocation along cytoskeletons. 6, 8 In proliferating cells, cytoplasmic NCL translocates to the cell surface via small vesicles, which is independent of the endoplasmic reticulum-Golgi pathway but requires N-linked glycosylation. 6, 14 Hovanessian et al 15 have reported that the surface NCL is de novo synthesized and constantly induced in both endothelial and tumor cells. Nevertheless, the molecular mechanism regarding the surface translocation of NCL is still poorly understood.
Here, we identified that heat shock cognate 70 (Hsc70), a molecular chaperone, is a novel NCL-interacting partner in endothelial cells. The interaction involved the RNA-binding domain (RBD) 3-4 of NCL and the peptide-binding domain (PBD) of Hsc70. Hsc70 regulated the surface translocation of NCL via enhancing its stability and its interaction with MyH9. Meanwhile, phosphorylation of NCL by protein kinase C-ξ (PKC-ξ) and casein kinase 2 (CK2), respectively, mediated its interaction with Hsc70 and influenced its surface expression. Moreover, Hsc70 was associated with the proangiogenic function of surface NCL. Taken together, our results shed light on the mechanism of NCL translocation coordinated by molecular chaperones and reveal that Hsc70 is critical for the expression and angiogenic function of cell surface NCL.
Methods

Cell Lines
Human umbilical vein endothelial cells (HUVECs) were purchased from ATCC (CRL-1730). Human microvascular endothelial cells (HMECs), a human dermal microvascular endothelial cell line (Sciencell, Carlsbad, CA) transfected with simian vacuolating virus 40 large T antigen, 16 were cultured by DMEM and 10% fetal bovine serum (Wisent, ST-BRUNO, QC, Canada).
Separation of Nucleus, Cytosol, and Membrane Fractions
HMECs were homogenized on ice in buffer A (25 mmol/L HEPES, 250 mmol/L sucrose, pH 7.4, protease and phosphatase inhibitor cocktails). Nucleus was pelleted by centrifugation at 1500g for 10 minutes and organelle components were removed by spinning at 8000g for 10 minutes. The membrane pellet was obtained by ultracentrifugation at 100 000g for 1 hour, and the supernatant was the cytosol fraction. Both nucleus and membrane pellets were dissolved in buffer B (50 mmol/L Tris, pH 7.5, 150 mmol/L NaCl, 1% Nonidet P-40, 1 mmol/L dithiothreitol, protease and phosphatase inhibitor cocktails).
Coimmunoprecipitation
Cell lysates or different fractions were preincubated with protein A/G agarose to reduce nonspecific binding. The cleared lysates were incubated with the antibody or isotype control IgG (1 μg/mg cell lysate) for 1 hour and subsequently with protein A/G beads (20 μL) for 6 hours at 4°C. After washing 3 times, the coimmunoprecipitation (co-IP) samples were subjected to SDS-PAGE or immunoblotting. Studies were repeated 3 times.
Liquid Chromatography-Mass Spectrometry
After NCL in the nucleus, cytosol, and membrane fractions of HMECs were immunoprecipitated, the co-IP samples were applied to SDS-PAGE and stained with Coomassie blue. Whole cell lysates immunoprecipitated with rabbit IgG served as negative control. Gel slices containing protein bands of great variation compared with control were excised and digested by sequencing grade modified trypsin. Peptide mixture was analyzed by liquid chromatography-mass spectrometry (Agilent 6300 Series Ion Trap Liquid Chromatography/ Mass Systems, Santa Clara, CA). Mass data were piloted by the Swiss-Prot database.
Immunofluorescence of Cell Surface Proteins
According to a previous study, 6 at 20°C, cells were incubated with primary antibodies for 1 hour, fixed with 4% formaldehyde for 30 minutes, blocked by 10% goat serum/PBS for 1 hour, and subsequently incubated with relevant fluorescein isothiocyanate-or tetramethylrhodamine isothiocyanate-conjugated secondary antibodies for 1 hour. Nuclei were stained with 4′-6-diamidino-2-phenylindole. Images were captured by a Nikon A1 confocal microscope. (Nikon, Tokyo, Japan).
Flow Cytometry
As previously described, 11 cells were blocked with 5% goat serum/ PBS, incubated with NCL antibody (5 μg/mL) or IgG isotype control, and stained with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (1 μg/mL). Cells were washed 3 times by PBS and analyzed by a FACSCalibur flow cytometry system (Becton Dickinson, San Jose, CA).
Transwell Migration
According to a previous study, 17 2×10 4 cells were seeded into the upper compartment of the transwell chambers and allowed to migrate for 6 hours. The lower compartment contained 900 μL complete growth medium. Cells were fixed and stained by crystal violet. All the transwell experiments were repeated 3 times and 3 wells for each treatment. The number of migrated cells was calculated in 5 random fields (×100).
Xenograft Tumor Model
According to a previous study, 18 human lung adenocarcinoma cells A549 (1×10 6 ) were inoculated subcutaneously into 6-week-old nude mice. When tumors reached ≈50 mm 3 , mice were separated into 2 groups, and, respectively, treated with dimethyl sulfoxide or 50 μg/g KNK437 every other day for 2 weeks.
Results
NCL Interacts With Hsc70 in Endothelial Cells
We and others have previously reported that cell surface NCL is a marker in angiogenic blood vessels and regulates tumor angiogenesis. 7, 8, 10 To investigate the regulatory mechanism underlying the surface translocation of NCL in endothelial cells, we searched for potential NCL-interacting proteins from the nucleus, cytosol, and membrane fractions. Immunoprecipitation and mass spectrometry analysis revealed that several proteins could bind with NCL; among them, a novel binding partner Hsc70 and MyH9 were simultaneously detected in both the cytosol and membrane compartments ( Figure 1A ). Thirteen distinct peptides covering most of the Hsc70 sequences were identified by mass spectrometry ( Figure IA in the online-only Data Supplement). We therefore explored whether Hsc70 interacts with NCL. We first examined their interaction in HUVECs by co-IP. NCL and Hsc70 were found to bind with each other when either NCL or Hsc70 was immunoprecipitated ( Figure 1B) . Next, we performed the pull-down experiment using purified green fluorescent protein-NCL to incubate with HUVEC lysates and immunoblotted the pull-down proteins with anti-Hsc70 antibody. Green fluorescent protein-NCL but not green fluorescent protein was able to pull-down Hsc70 ( Figure IB in the online-only Data Supplement). By immunofluorescence assay, we found that NCL colocalized with Hsc70 in endothelial cells ( Figure 1C ; Figure IC in the online-only Data Supplement). Moreover, the colocalization between NCL and Hsc70 was also observed in the vascular-like regions of human tumor tissues ( Figure 1C ). Taken together, these results demonstrate that NCL forms a complex with Hsc70 in endothelial cells.
The RBD of NCL and the PBD of Hsc70 Are Indispensable for the Interaction Between NCL and Hsc70
NCL is composed of 3 structural domains, including the N-terminal domain comprising 4 acidic stretches (N-domain), the central globular region containing 4 RBD (RBD 1-4), and the C-terminal domain rich in arginine and glycine residues (RGG domain). 19 To determine the interacting domain of NCL with Hsc70, we constructed a series of green fluorescent protein-tagged truncations (NCL WT , NCLΔ , NCLΔ , NCLΔ , and NCLΔ ) encompassing various functional domains of NCL ( Figure 1D , top). After transfecting HMECs with different NCL truncations, we detected their interactions with Hsc70 by co-IP. Compared with NCL WT , the interaction between NCLΔ 307-707 and Hsc70 was dramatically disrupted, whereas that of NCLΔ was not influenced (Figure 1D, bottom) . Meanwhile, NCLΔ rather than NCLΔ 469-707 could interact with Hsc70 ( Figure 1D , bottom), indicating that the regulatory domain resides in the amino acid region 469 to 647 of NCL, which is defined as the RBD 3-4. Hsc70 contains an ATP-binding domain, a PBD, and a C-terminal domain. To investigate the binding domain of Hsc70 with NCL, we performed the co-IP assay with hemagglutinin-tagged Hsc70 constructs covering the entire length of Hsc70 ( Figure 1E , top). Immunoblotting revealed that the PBD of Hsc70 was required for its interaction with NCL ( Figure 1E , bottom). Likewise, clusters of surface NCL were found to colocalize with Hsc70 and Hsc70ΔATP rather than Hsc70ΔPBD in HMECs ( Figure 1F ). The aforementioned results demonstrate that the RBD 3-4 of NCL and the PBD of Hsc70 are responsible for their interaction.
Hsc70 Regulates the Surface Translocation of NCL
Hsc70 has been shown to regulate the trafficking of several proteins, including aquaporin-2, acid sensitive ion channel 2 (ASIC2), cystic fibrosis transmembrane conductance regulator (CFTR), and melanocortin-4 receptor. [20] [21] [22] [23] [24] Because Hsc70 interacts with NCL, we speculated that Hsc70 participates in the NCL translocation. First, we treated HUVECs with an Hsc70 inhibitor KNK437 for different time. KNK437 significantly inhibited the expression of Hsc70 as early as 3 hours compared with heat shock protein 70 (Hsp70), Hsp90α, and Hsp90β ( Figure IIA in the online-only Data Supplement). Then, we incubated HUVECs with KNK437 at different concentrations and found that the expression of membrane NCL was receded when the KNK437 concentration was increased ( Figure 2A ). The inhibitory effect of KNK437 on the surface NCL was further verified by flow cytometry ( Figure 2B ) and immunofluorescence ( Figure 2C ), respectively. Second, we knocked down Hsc70 in proliferating HUVECs or overexpressed Hsc70 in serum-starved HUVECs ( Figure IIB in the online-only Data Supplement), and subsequently detected the expression of surface NCL by flow cytometry. The absence of Hsc70 led to a decrease of surface NCL, whereas the overexpression of Hsc70 resulted in the induction of surface NCL ( Figure 2D ). To further elucidate the effect of Hsc70 on NCL translocation, we detected the expression of NCL in plasma membrane, cytosol, and nucleus fractions. After knocking down Hsc70, membrane NCL was downregulated and cytosolic NCL was slightly accumulated, whereas nuclear NCL was marginally changed ( Figure 2E ). Then, we immunostained and detected surface NCL by confocal microscopy after altering the expression of Hsc70. As expected, a dramatic reduction of surface NCL occurred as a result of the loss of Hsc70, whereas surface NCL accumulated as a result of Hsc70 overexpression ( Figure 2F) . Moreover, the expression of surface NCL in Hsc70 knockdown cells was rescued by the transfection of Hsc70, but neither Hsc70ΔATP nor Hsc70ΔPBD ( Figure 2G ). Therefore, both the ATP-binding domain and PBD of Hsc70 are required for the surface translocation of NCL, which, respectively, provide ATPase activity and NCL-binding region. Collectively, these results show that Hsc70 is involved in the surface translocation of NCL.
Phosphorylation of NCL Mediates Its Interaction With Hsc70 and the Surface Translocation
Because NCL is massively phosphorylated in vivo, 2 we wondered whether phosphorylation regulates the interaction between NCL and Hsc70. Endogenous NCL was immunoprecipitated from HUVEC extracts and immunoprecipitates were treated with λ protein phosphatase to inhibit protein phosphorylation. λ protein phosphatase impaired the complex between NCL and Hsc70, which suggests that NCL binds to Hsc70 in a phosphorylation-dependent manner ( Figure IIIA in the onlineonly Data Supplement). NCL has been reported to be phosphorylated by PKC-ξ, CK2, and cell division control protein 2 in vivo. 2 To examine whether the phosphorylation of NCL by these kinases was required for its interaction with Hsc70, we treated HUVECs with inhibitors of PKC, CK2, and cell division control protein 2, respectively, and immunoprecipitated NCL afterward. The phosphorylation of NCL was suppressed by these inhibitors ( Figure IIIB in the online-only Data Supplement). The interaction between NCL and Hsc70 was attenuated on the inhibition of either PKC or CK2 ( Figure 3A) . Then, we detected whether the phosphorylation of NCL can affect its surface expression by both immunofluorescence and flow cytometry. As expected, suppression of either PKC-ξ or CK2 by chemical inhibitors downregulated the expression of surface NCL ( Figure 3B ; Figure IIIC in the online-only Data , and 100 μmol/L) for 1 hour, and then serum-rescued for 6 hours to restore surface NCL expression. NCL and Hsc70 in both membrane fractions and whole cell lysates (WCL) were immunoblotted. CD31 and GAPDH were loading controls. The ratio of membrane NCL/CD31 was quantified in each group. B and C, HUVECs were serum-starved for 24 hours, pretreated by dimethyl sulfoxide (DMSO) (control) or KNK437 (100 μmol/L) for 1 hour, and then serum-rescued for 6 hours. B, Surface NCL was monitored by flow cytometry. C, Cell surface NCL and Hsc70 in HUVECs were detected by immunofluorescence. Nuclei were indicated by 4′-6-diamidino-2-phenylindole (DAPI) staining. Scale bar=20 μm. D, Proliferating HUVECs were transfected with scrambled siRNA (S.C.) or Hsc70 siRNA (Si-Hsc70). HUVECs transfected with pcDNA3.1 (vehicle) or pcDNA3.1-Hsc70 (Hsc70) plasmids were starved by 2% serum for 24 hours. Cells were incubated with anti-NCL antibody or IgG isotype control (N.C.) and then with fluorescein isothiocyanate (FITC)-conjugated secondary antibody, and analyzed by flow cytometry. E, Proliferating HUVECs were transfected with S.C. or Hsc70 siRNA (Si-Hsc70) and subsequently separated into membrane (Mem-), cytosol (Cyto-), and nucleus (Nu-) compartments. NCL and Hsc70 were detected by immunoblotting. CD31, GAPDH, and Lamin B are, respectively, the loading controls of membrane, cytosol, and nucleus. The ratio of NCL/loading control was quantified in each group. F, Proliferating HUVECs were transfected with S.C. or Hsc70 siRNA (Si-Hsc70). HUVECs transfected with pcDNA3.1 (vehicle) or pcDNA3.1-Hsc70 (Hsc70) plasmids were serum-starved for 24 hours. Surface NCL was analyzed by immunofluorescence. Scale bar=10 μm. G, Hsc70 was knocked down in HUVECs and rescued by transfection of full-length Hsc70 (FL), Hsc70ΔATP, and Hsc70ΔPBD constructs. Surface NCL was detected by flow cytometry. N.C. indicated cells incubated with rabbit IgG; MFI, mean fluorescence intensity. Supplement) and attenuated the NCL cluster formation on the cell surface ( Figure 3B ). Next, we knocked down PKC-ξ, CK2, and cell division control protein 2 and then immunoprecipitated NCL. Consistently, the interaction between NCL and Hsc70 was inhibited after knocking down PKC-ξ or CK2 ( Figure 3C) . Meanwhile, the expression of surface NCL was decreased as a result of knocking down either PKC-ξ or CK2 ( Figure 3D ; Figure IIID in the online-only Data Supplement). In summary, these results suggest that the phosphorylation of NCL by PKC-ξ and CK2 mediates the surface translocation of NCL via regulating its interaction with Hsc70.
Hsc70 Stabilizes NCL and Enhances the Interaction Between NCL and MyH9 in Endothelial Cells
Previous studies have shown that the stability of NCL is positively correlated with the cell proliferation status. 25 Meanwhile, the expression of surface NCL is much higher in proliferating cells compared with that in quiescent cells, 7, 8, 11 which indicates that the integrity of NCL is related to its surface expression. Thus, we wondered whether Hsc70 influences the stability of NCL. We first detected whether the interaction between NCL and Hsc70 alters under different cell proliferation status. As expected, the interaction was reduced in quiescent cells compared with that in proliferating cells ( Figure 4A ), which suggests that the interaction with Hsc70 may be related to the stability of NCL. To further assess this issue, we knocked down Hsc70 and detected NCL in the whole cell lysates by immunoblotting. Degradation of NCL was increased as a result of knocking down Hsc70 ( Figure 4B) . Intriguingly, the stability of NCL was restored when the expression of Hsc70 was rescued by transfection of Hsc70 rather than Hsc70ΔATP or Hsc70ΔPBD ( Figure 4B ). Moreover, Huang et al 8 have reported that MyH9 serves as a motor for the surface translocation of NCL. Here, we found that the RGG domain of NCL was required for its interaction with MyH9 ( Figure IV in the online-only Data Supplement). We therefore explored whether Hsc70 affects the interaction between NCL and MyH9, which in turn regulates NCL translocation. By immunoprecipitation, we found that the interaction between NCL and MyH9 was decreased as a result of knocking down Hsc70 ( Figure  4B ), which was restored by the rescue of Hsc70 other than Hsc70ΔATP or Hsc70ΔPBD ( Figure 4B ). Meanwhile, the interaction between NCL and MyH9 was correlated with the stability of NCL ( Figure 4B ). These results demonstrate that Hsc70 stabilizes NCL and mediates the interaction between NCL and MyH9.
Hsc70 Regulates the Angiogenic Function of Cell Surface NCL
Because surface NCL has been well documented in angiogenesis, 7, 8, 11 we thus hypothesized that the angiogenic function of NCL can be regulated by Hsc70. It has been reported that surface NCL regulates endothelial cell migration while only marginally affecting cell adhesion and proliferation. 8 To evaluate the effect of Hsc70 on surface NCLinduced cell migration, we overexpressed NCL in HMECs to enhance the level of surface NCL and simultaneously knocked down Hsc70. In the transwell migration assay, we found that the upregulation of NCL led to enhanced cell migration compared with the vehicle group. However, lack Figure 3 . Phosphorylation of nucleolin (NCL) regulates its interaction with heat shock cognate 70 (Hsc70) and its surface expression. A, Human umbilical vein endothelial cells (HUVECs) were treated with dimethyl sulfoxide (DMSO) (control), staurosporine (iPKC-ξ), casein kinase 2 (CK2) inhibitor IV (iCK2), or olomoucine (iCdc2) for 12 hours. After NCL in cell lysates was immunoprecipitated, Hsc70 and NCL were detected by immunoblotting. Hsc70 and GAPDH in cell lysates were immunoblotted as input controls. The ratio of coimmunoprecipitated Hsc70/input Hsc70 was quantified. B, HUVECs were serum-starved for 24 hours, pretreated with iPKC-ξ, iCK2, or iCdc2 for 1 hour, and serum-rescued for 12 hours. Surface NCL and CD31 (control) were detected by immunofluorescence. Nuclei were indicated by 4′-6-diamidino-2-phenylindole (DAPI) staining. Scale bar=20 μm. C, HUVECs were transfected with PKC-ξ, CK2, or Cdc2 siRNAs and applied to coimmunoprecipitation (co-IP). Co-IP samples were immunoblotted against Hsc70 and NCL (top). The knocking down efficiency was shown at the bottom. The ratio of coimmunoprecipitated Hsc70/NCL was quantified. D, After PKC-ξ, CK2, or Cdc2 were knocked down in HUVECs, surface NCL and CD31 (control) were detected by immunofluorescence. Nuclei were indicated by DAPI staining. Scale bar=20 μm. Cdc2 indicates cell division control protein 2; PKC-ξ, protein kinase C-ξ; S.C., scrambled siRNA.
of Hsc70 impaired the cell motility induced by NCL overexpression ( Figure 5A ). A similar result was observed in the scratch migration assay ( Figure V in the online-only Data Supplement), which indicated that Hsc70 regulates the cell motility induced by surface NCL. To extend this finding, we investigated whether knockdown of Hsc70 suppressed endothelial tubule formation. Transfected HMECs were seeded on matrigel, and knockdown of Hsc70 significantly attenuated the tubule formation induced by the overexpression of NCL ( Figure 5B ). Furthermore, we examined the functional role of Hsc70 on NCL-related angiogenesis in matrigel plugs. Mice were implanted with matrigel plugs and injected by dimethyl sulfoxide or KNK437. Immunofluorescence of matrigel plugs showed that KNK437 apparently reduced both the blood vessel density and the expression of NCL on blood vessels ( Figure 5C ). Meanwhile, the colocalization between NCL and Hsc70 in matrigel plugs was attenuated as a result of KNK437 treatment ( Figure 5D ). Collectively, these results strongly support that Hsc70 is responsible for the proangiogenic role of cell surface NCL.
Hsc70 Participates in NCI-Associated Tumor Angiogenesis
Considering that Hsc70 regulates NCL-induced angiogenesis, we further investigated their relationship in tumor angiogenesis. Mice bearing A549 xenograft tumors were treated with dimethyl sulfoxide or KNK437. After injection for 2 weeks, tumors were sectioned and immunostained with the endothelial cell marker CD31, NCL, and Hsc70. Consistent with previous results, either the blood vessel density or the expression of NCL on blood vessels was much lower in the KNK437-treated group ( Figure 6A) . Moreover, KNK437 ultimately inhibited the colocalization between NCL and Hsc70 as a result of the reduction of both NCL on blood vessels and Hsc70 expression ( Figure 6B ). To further confirm the association between Hsc70 and NCL in tumor angiogenesis, we investigated their expression in both normal lung and nonsmall-cell lung cancer tissues. Immunostaining analysis represented that there was almost no expression of Hsc70 and NCL in normal lung tissues, whereas their expression varied in different tumor specimens. Among 40 tumor specimens, blood vessels of 27 cases lack Hsc70 and NCL (low Hsc70-low NCL). In 10 specimens, the expression of both Hsc70 and NCL on blood vessels was >50% (high Hsc70-high NCL). Hsc70 but no NCL was detected in the blood vessels of another 3 cases ( Figure 6C ). Therefore, Hsc70 and NCL are mostly coexpressed and colocalized on the blood vessels of human lung tumor tissues. Intriguingly, none of the 40 human tumor tissues showed low Hsc70 but high NCL on blood vessels, which again supports that Hsc70 is a prerequisite for the surface translocation of NCL in endothelial cells. Taken together, these results demonstrate that Hsc70 participates in NCL-associated tumor angiogenesis.
Discussion
Although NCL is primarily characterized as a nucleolar protein, it is also localized on the cell surface. During its surface translocation, NCL must interact with a host of accessory proteins. Understanding these interactions is crucial for unraveling the mysteries of the translocation, postmodification, and functions of NCL. Here, we provide direct evidences regarding the interaction between NCL and the chaperone system. We investigated the relationship between Hsc70 and NCL, in that Hsc70 was identified to interact with NCL in both the plasma membrane and the cytosol using mass spectrometry. Further, by co-IP and immunofluorescence, we first demonstrate that Hsc70 interacts with NCL in endothelial cells. The RBD 3-4 of NCL and the PBD of Hsc70 are responsible for their interaction. Interestingly, among NCL truncations, NCLΔ 1−303 has shown the robust binding with Hsc70 ( Figure 1D ), indicating that the N domain of NCL plays a regulatory role in their interaction. The N domain of NCL is rich in lengthy acidic amino acids. Because the PBD of Hsc70 is inclined to bind with hydrophobic and basic amino acids, but few or no acidic residues, 26 the N domain of NCL is likely to prohibit its interaction with Hsc70. Moreover, the phosphorylation status of NCL by PKC-ξ and CK2 also mediates the complex formation. The exact structural characteristics of the NCL-Hsc70 complex merit further investigation.
A key question, therefore, is how this interaction regulates NCL translocation. We found that suppression of Hsc70 impedes the expression of surface NCL, which can be restored by the rescue of Hsc70 (Figure 2 ). These observations illustrate that interacting with Hsc70 is crucial for the surface translocation of NCL. It is noteworthy that Hsc70 is a critical regulator of protein trafficking. On one hand, several studies have reported that Hsc70 participates in the clathrin-mediated endocytosis and functions as an ATPase in the disassembly of clathrin-coated vesicles. 27 In this respect, Hsc70 restrains the expression of membrane aquaporin-2, ASIC2, and CFTR. [20] [21] [22] [23] On the other hand, Hsc70 is a chaperone, which can facilitate the correct folding and the stability of client proteins. 28, 29 For instance, Hsc70 promotes the surface translocation of melanocortin-4 receptor by improving its folding. 24 Therefore, Hsc70 regulates the trafficking of various proteins via distinct mechanisms. Currently, we demonstrate that Hsc70 enhances the surface translocation of NCL. Because NCL is found to colocalize with Hsc70 both in the cytosol and on the surface of endothelial cells, it is reasonable to deduce that Hsc70 accompanies NCL during its surface translocation process. Our mass spectrometry analysis reveals several other potential NCL-binding proteins in cytosol, including Hsp90α and enolase-1 ( Figure 1A) . Interestingly, Hsc70, Hsp90α, and enolase-1 are all exosome components, which are crucial for protein secretion. 30, 31 More investigations are required to characterize whether the surface translocation of NCL is associated with exosome.
NCL undergoes multiple postmodifications intracellularly, including phosphorylation, glycosylation, methylation, and proteolysis.
2 N-glycosylation has been identified essential for the expression of surface NCL. 14 The phosphorylation of NCL has been mostly studied and demonstrated to be regulated by PKC-ξ, CK2, and cell division control protein 2. Particularly, suppression of PKC-ξ and CK2 impedes the interaction between Hsc70 and NCL, which causes the decrease of surface NCL. Further explorations are needed to elucidate the exact phosphorylation sites, which are indispensible for the surface translocation of NCL, as well as the variations of NCL phosphorylation status in different cellular compartments. Meanwhile, our group has reported that the phosphorylation of Thr90 on Hsp90α facilitates its secretion in tumor cells, which stabilizes matrix metalloproteinase-2 [32] [33] [34] ; therefore, that the phosphorylation of Hsc70 may also mediate the surface translocation of NCL cannot be ruled out and merits further investigation. transfected HMECs were seeded in each well of the matrigel-coated plates and incubated for 6 hours in complete growth medium, cells were fixed and visualized by microscope (×100, top). Relative tubule length was assessed in 3 randomly selected fields per well using Scion Image (bottom). C and D, Mice were inoculated with matrigel plugs and treated by DMSO or KNK437. Frozen sections of matrigel plugs were stained with CD31 (blood vessels, BV) and NCL in C, and Hsc70 and NCL in D. Nuclei were indicated by 4′-6-diamidino-2-phenylindole (DAPI) staining. Bars, 100 μm (4 left panels) and 25 μm (magnified). Quantified BV, NCL, on BV (C), and colocalized Hsc70-NCL (D) were shown at the bottom. e133
Cell surface NCL has been implicated in angiogenesis via regulating endothelial cell migration. 8, 10 During the surface mobilization of NCL, stress fibers and focal adhesion complex form simultaneously. 8 Because the dynamic of focal adhesions plays a central role in cell migration, it is likely that the proangiogenic role of surface NCL is correlated with focal adhesions. Intriguingly, our mass spectrometry analysis reveals that talin, an essential focal adhesion molecule, potentially interacts with NCL. Surface NCL can be diminished by knocking down talin (Figure VI in the online-only Data Supplement). Previously, we have reported that NCL mediates the internalization of endostatin. 11, 35 In a further study, we found that surface NCL forms a complex with integrin α5β1, 36 which is responsible for the connection between focal adhesions and extracellular matrix. 37 Our results, in conjugation with previous studies, underscore the possibility that cell migration induced by surface NCL is associated with focal adhesions. More importantly, we demonstrate that Hsc70 mediates the angiogenic function of surface NCL. Suppressing Hsc70 abolishes angiogenesis induced by NCL. Meanwhile, we observed that in the presence of fetal bovine serum, knocking down Hsc70 exclusively inhibits endothelial cell migration and tubule formation. This result is consistent with previous studies, demonstrating that the inhibition of Hsc70 by KNK437 downregulates multiple endothelial functions via the PI3K/Akt pathway in the presence of vascular endothelial growth factor, 38 because vascular endothelial growth factor can mobilize the surface translocation of NCL. Our study unravels a novel mechanism underlying the critical role of Hsc70 in angiogenesis, which is associated with the surface translocation of NCL.
Hsc70 and Hsp70 share high homology in both structure and physiological functions as chaperones. Recent studies have suggested that Hsc70 and Hsp70 are distinguishably different under certain circumstances. [39] [40] [41] Hsc70 is constitutively expressed and participates in cellular processes of normal cells, such as endothelial cells. It serves as a scaffold protein and coordinates the regulation of signal transduction 32 and cell survival. 42 In contrast, Hsp70 is expressed at significantly low levels in most unstressed cells but can be rapidly induced by physical and chemical stresses. In our present study, only Hsc70, but not Hsp70, was identified as a potential NCL-interacting protein in endothelial cells. We propose that Hsc70 and Hsp70 have differential roles in regulating NCL translocation. Particularly, it is reported that NCL mRNA is induced after a heat shock stress which is concomitant with a strong induction of Hsp70 mRNA, 15 directly resulting in the increment of surface NCL. On the basis of these observations, we speculated that Hsc70 regulates the trafficking of NCL in normal cells, whereas Hsp70 may participate in this process under stress conditions.
In conclusion, our present study identifies a novel mechanism underlying the surface translocation of NCL ( Figure  VII in the online-only Data Supplement). Hsc70 interacts with NCL and modulates the surface translocation of NCL via enhancing its stability and the interaction with MyH9. Phosphorylation of NCL by PKC-ξ and CK2 remarkably influences its interaction with Hsc70 and consequently regulates its surface expression. Furthermore, Hsc70 is intimately associated with the angiogenic function of surface NCL. This study, for the first time, demonstrates that Hsc70 is a prerequisite for the expression and angiogenic function of surface Nuclei were indicated by 4′-6-diamidino-2-phenylindole (DAPI) staining. Bars, 100 μm (4 left panels) and 25 μm (magnified). Quantified BV, NCL, on BV (A), and colocalized Hsc70-NCL (B) are shown in the right. C, The tissue array containing 5 normal lung tissues and 40 cases of non-small-cell lung cancer tissues was incubated with anti-NCL, anti-Hsc70, and anti-CD31 antibodies, subsequently stained with fluorescein isothiocyanate (FITC)-, tetramethylrhodamine isothiocyanate-, and Cy5-conjugated secondary antibodies, and analyzed by confocal microscopy. Nuclei were indicated by DAPI staining. Bars, 100 μm (5 left panels) and 50 μm (magnified). Tumor tissues were divided into 3 groups according to different expression of Hsc70 and NCL. Quantification of the specimen in different groups was presented.
NCL, which suggests strategies to target both Hsc70 and NCL for more effective antiangiogenic therapies.
